Zhang Shile, Lee Ernie, Bopardikar Sachi, Goldstein Andrew S
Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine, Los Angeles, California, USA.
Department of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, California, USA.
Endocr Relat Cancer. 2025 Sep 22;32(9). doi: 10.1530/ERC-25-0026. Print 2025 Sep 1.
Age is a major risk factor for a range of diseases, including prostate cancer. Understanding how age influences the susceptibility of normal prostate epithelial cells to cancer initiation is complicated by the fact that aging affects all tissues in the body. Assessing how various aging mechanisms influence the prostate epithelium is a necessary step to determine the critical factors associated with aging that increase prostate cancer risk. Here, we take a broad view of both prostate epithelial cell-intrinsic and cell-extrinsic factors that change with age and are likely to contribute to age-related risk of prostate tumorigenesis. For each factor, we discuss the impact of these age-related changes on cancer risk. We highlight important areas where additional research is required to help decipher the specific age-associated changes that contribute to prostate cancer initiation. Finally, we address the potential impact of various therapeutic interventions on aging phenotypes and cancer risk.
年龄是包括前列腺癌在内的一系列疾病的主要风险因素。由于衰老会影响身体的所有组织,因此了解年龄如何影响正常前列腺上皮细胞对癌症起始的易感性变得复杂。评估各种衰老机制如何影响前列腺上皮是确定与衰老相关的增加前列腺癌风险的关键因素的必要步骤。在这里,我们广泛审视了随着年龄变化的前列腺上皮细胞内在和外在因素,这些因素可能导致与年龄相关的前列腺肿瘤发生风险。对于每个因素,我们讨论这些与年龄相关的变化对癌症风险的影响。我们强调了需要进一步研究以帮助解读导致前列腺癌起始的特定年龄相关变化的重要领域。最后,我们探讨了各种治疗干预对衰老表型和癌症风险的潜在影响。